Pharma BD Deal Intelligence
GSK plc / Human Genome Sciences
2012 · Acquisition/Merger · $3.6B · Complete
Announcement Sentiment
75
Strongly positive
Outcome Score
70
Largely worked — most objectives met.
GSK acquired Human Genome Sciences for $3B for lupus and diabetes treatments.
Key facts
- Announced Jul 16, 2012
- Closed Aug 02, 2012
- Deal value $3.6B
- Deal type Acquisition/Merger
- Therapeutic area Immunology
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals